HTB homepage • Conference reports • Articles by subject • Subscribe 11 February 2006 Contents Conference reports 10th European AIDS Conference (EACS), 17-20 November 2005, Dublin, Ireland Rifaximin cure reported for cryptosporidium in advanced HIV Analysis of hepatic events in 2NN study by CD4 entry criteria, levels differences between nevirapine and efavirenz; excess hepatic events in once-daily nevirapine arm linked to single site in Thailand FTC studies at EACS: reduced incidence of M184V compared to 3TC; side effect profile in clinical practice Paediatric studies at EACS: trends in antiretroviral use in the Madrid Cohort; life expectancy significantly increased HIV/HCV co-infected children since HAART; use of tenofovir in treatment experienced children; switching to lopinavir/r from double protease inhibitor regimen; once daily lopinavir/r, 3TC and abacavir; planned treatment interruptions in children Efficacy of lopinavir/r in patients with advanced HIV (CD4 <25 cells/mm3) Potential barriers to use of T-20: results from patient and physician interviews Factors associated with sexual dysfunction in HIV patients Decreased varicella zoster immunity in migrants from sub-Saharan Africa Clinical experience of switching to atazanavir in the UKs largest clinic Replacing a PI with atazanavir: separating swans from ducklings? TMC 125: some good and bad news When to change a failing regimen: second-line and salvage strategies Antiretrovirals and other stuff! Heart disease in people with HIV Mortality trends: why people with HIV die (or dont) today HTB homepage • Conference reports • Articles by subject • Subscribe